1-(3,4-Dichloro-phenyl)-3-aza-bicyclo[3.1.0]hexane HCl manufacturers
- CL-216303 HCl
-
- $1980.00
-
2026-05-11
- CAS:86215-36-3
- Purity:
- Supply Ability: 10g
|
| | 1-(3,4-Dichloro-phenyl)-3-aza-bicyclo[3.1.0]hexane HCl Basic information |
| | 1-(3,4-Dichloro-phenyl)-3-aza-bicyclo[3.1.0]hexane HCl Chemical Properties |
| storage temp. | -20°C | | solubility | DMSO: ≥10mg/mL | | form | powder | | color | white to beige | | InChI | 1S/C11H11Cl2N.ClH/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11;/h1-3,8,14H,4-6H2;1H | | InChIKey | KAGBHVBIOJBGBD-UHFFFAOYSA-N | | SMILES | Cl.Clc1ccc(cc1Cl)C23CNCC2C3 | | CAS DataBase Reference | 86215-36-3 |
| Hazard Codes | T | | Risk Statements | 25-36 | | Safety Statements | 26-45 | | RIDADR | UN 2811 6.1 / PGIII | | WGK Germany | 3 | | Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects | | Hazard Classifications | Acute Tox. 3 Oral Eye Irrit. 2 |
| | 1-(3,4-Dichloro-phenyl)-3-aza-bicyclo[3.1.0]hexane HCl Usage And Synthesis |
| Uses | DOV-216,303 is an antidepressant compound. DOV-216,303 inhibits the reuptake of norepinephrine (NE), serotonin (5‐HT), and dopamine (DA), with IC50 values of 14 nM, 20 nM and 78 nM for hSERT, hNET and hDAT, respectively. DOV-216,303 increases monoamine release in the prefrontal cortex of olfactory bulbectomized (OBX) rats[1][2][3]. | | Biological Activity | Triple reuptake inhibitor (TRI); serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI); IC50 values of ~20, 14, and 78 nM, respectively. | | References | [1] Skolnick P, et al. Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor. CNS Drug Rev. 2006 Summer;12(2):123-34. DOI:10.1111/j.1527-3458.2006.00123.x [2] Shao L, et al. Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1438-41. DOI:10.1016/j.bmcl.2011.01.016 [3] Prins J, et al. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats. Eur J Pharmacol. 2010 May 10;633(1-3):55-61. DOI:10.1095/biolreprod44.3.561 |
| | 1-(3,4-Dichloro-phenyl)-3-aza-bicyclo[3.1.0]hexane HCl Preparation Products And Raw materials |
|